These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8522699)

  • 1. Subacute occlusion, bleeding complications, hospital stay and restenosis after Palmaz-Schatz coronary stenting under a new antithrombotic regimen.
    Fernández-Avilés F; Alonso JJ; Durán JM; Gimeno F; Muñoz JC; de la Fuente L; San Román JA
    J Am Coll Cardiol; 1996 Jan; 27(1):22-9. PubMed ID: 8522699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No subacute thrombosis and femoral bleeding complications under full anticoagulation in 150 consecutive patients receiving non-heparin-coated intracoronary Palmaz-Schatz stents.
    Lee SW; Chen MZ; Chan HW; Lam L; Guo JX; Mao JM; Lam KK; Guo LJ; Li HY; Chan KK
    Am Heart J; 1996 Dec; 132(6):1135-46. PubMed ID: 8969564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
    Neumann FJ; Gawaz M; Ott I; May A; Mössmer G; Schömig A
    J Am Coll Cardiol; 1996 Jan; 27(1):15-21. PubMed ID: 8522689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immediate and long-term clinical and angiographic results of the Wiktor stent in the treatment of chronic coronary occlusions].
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Marazzi G; Vicedomini G; Pagnotta P; Montorfano M; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    G Ital Cardiol; 1997 Sep; 27(9):881-91. PubMed ID: 9378193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transradial Palmaz-Schatz coronary stenting on an outpatient basis: results of a prospective pilot study.
    Kiemeneij F; Laarman GJ; Slagboom T; Stella P
    J Invasive Cardiol; 1995; 7 Suppl A():5A-11A. PubMed ID: 10155117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP
    Am Heart J; 1997 Nov; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasound.
    Hall P; Nakamura S; Maiello L; Almagor Y; Gaglione A; Goldberg SL; Tobis JM; Martini G; Tucci G; Di Maggio M
    J Invasive Cardiol; 1995; 7 Suppl A():12A-22A. PubMed ID: 10155111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.
    Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
    J Am Coll Cardiol; 1998 Feb; 31(2):281-8. PubMed ID: 9462568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
    Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
    Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
    Zubaid M; Penn IM; Buller CE; Moscovich MD; Ricci DR; Chauhan A
    Can J Cardiol; 1997 Apr; 13(4):335-40. PubMed ID: 9141964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
    Schömig A; Neumann FJ; Walter H; Schühlen H; Hadamitzky M; Zitzmann-Roth EM; Dirschinger J; Hausleiter J; Blasini R; Schmitt C; Alt E; Kastrati A
    J Am Coll Cardiol; 1997 Jan; 29(1):28-34. PubMed ID: 8996291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.
    Bertrand ME; Legrand V; Boland J; Fleck E; Bonnier J; Emmanuelson H; Vrolix M; Missault L; Chierchia S; Casaccia M; Niccoli L; Oto A; White C; Webb-Peploe M; Van Belle E; McFadden EP
    Circulation; 1998 Oct; 98(16):1597-603. PubMed ID: 9778323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2.
    Haude M; Hafner G; Jablonka A; Rupprecht HJ; Prellwitz W; Meyer J; Erbel R
    Am Heart J; 1995 Aug; 130(2):228-38. PubMed ID: 7631600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.
    Schühlen H; Hadamitzky M; Walter H; Ulm K; Schömig A
    Circulation; 1997 Apr; 95(8):2015-21. PubMed ID: 9133509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of major in-hospital ischemic complications and length of hospital stay after coronary stenting.
    De Servi S; Repetto S; Bossi I; Colombo A; Klugmann S; Bartorelli A; Piva R; Niccoli L; Rubartelli P; Giommi L; Vassanelli C; Baduini G; Chioin R; Bedogni F; Fontanelli A; Maresta A; Cernigliaro C; Geraci S
    G Ital Cardiol; 1998 Dec; 28(12):1345-53. PubMed ID: 9887387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy after coronary stent placement.
    Marzocchi A; Piovaccari G; Marrozzini C; Ortolani P; Palmerini T; Branzi A; Magnani B
    Cardiologia; 1998 Jul; 43(7):717-23. PubMed ID: 9738329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary stenting in 1000 consecutive patients. Long-term clinical and angiographic results.
    Colombo A; Di Mario C; Reimers B; Blengino S; Akiyama T; Ferraro M; Martini G; Di Francesco L; Finci L
    G Ital Cardiol; 1997 Jan; 27(1):19-31. PubMed ID: 9199940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
    Haushofer A; Halbmayer WM; Dittel M; Prachar H; Mlczoch J; Fischer M
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):697-706. PubMed ID: 7865675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Kopp CW; Steiner S; Priglinger U; Christ G; Probst P; Maurer G; Minar E; Huber K
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):379-86. PubMed ID: 12945880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.